Truist Securities has reaffirmed its Buy rating for Centene (NYSE:CNC) with a $47 price target, following the company’s fourth-quarter results. Centene’s stock is considered undervalued by InvestingPro data, trading at $38.14, despite challenges like a 10.5% gross profit margin. The firm anticipates significant margin improvement in Centene’s Marketplace segment and stability in Medicaid, with Medicare Advantage moving towards breakeven by 2027.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Truist Securities reiterates Buy rating on Centene stock with $47 target
Truist Securities has reaffirmed its Buy rating for Centene (NYSE:CNC) with a $47 price target, following the company’s fourth-quarter results. Centene’s stock is considered undervalued by InvestingPro data, trading at $38.14, despite challenges like a 10.5% gross profit margin. The firm anticipates significant margin improvement in Centene’s Marketplace segment and stability in Medicaid, with Medicare Advantage moving towards breakeven by 2027.